<strong>Background:</strong> In Graves’s disease, there is a lack of description specific to the gender and age among sub-Saharan African subject. The objective was to evaluate the impact of gender and ag...<strong>Background:</strong> In Graves’s disease, there is a lack of description specific to the gender and age among sub-Saharan African subject. The objective was to evaluate the impact of gender and age on the profile of Graves’ disease in Senegalese subject in order to understand the evolution and improve the therapeutic choices. <strong>Methods:</strong> This is a retrospective study conducted from January 1, 2010 to December 31, 2017 (07 years) at Abass Ndao University Hospital (Senegal), focused on patients with Graves’ disease followed up under antithyroid drugs treatment for at least 18 months. <strong>Results:</strong> There were 244 men, 404 subjects between [0 - 25 years], and 101 subjects more than 50 years old. Factors associated with goitre size were male gender (p < 0.001), young age (p < 0.001). Graves orbitopathy was correlated with male gender (p = 0.015), and young age (p < 0.001). Among 580 patients who had stopped medical treatment after more than 18 months of follow-up, relapse involved in 30.3%. Durable remission was achieved in 38.8% of all included patients and 69.7% of subjects who had a cessation of medical treatment. The factors associated with sustained remission were female gender (p = 0.049), absence of orbitopathy (p = 0.011), small goiter (p < 0.001), advanced age (p = 0.006) and early start of the maintenance treatment (p = 0.006). <strong>Conclusion:</strong> In our Senegalese study, men and young patients are particularized by a trend of voluminous goitre and low rate of remission. These data remain a basis for predicting the outcome of medical treatment and make timely use of radical treatments such as surgery or irratherapy in the presence of risk factors for recurrence.展开更多
目的探讨三维适形(含电子线照射野)的照射技术治疗双眶Grave’s眼病的实施方法及其剂量学优势。方法10例确诊为双侧Grave’s眼病的患者,均用三维适形(含电子线照射野)照射技术、传统的对穿野照射技术以及近年来主流的调强照射技术等三...目的探讨三维适形(含电子线照射野)的照射技术治疗双眶Grave’s眼病的实施方法及其剂量学优势。方法10例确诊为双侧Grave’s眼病的患者,均用三维适形(含电子线照射野)照射技术、传统的对穿野照射技术以及近年来主流的调强照射技术等三种技术完成治疗计划,比较计划靶区(planning target volume,PTV)和危及器官(organ at risk,OAR)的剂量分布图、剂量体积直方图和剂量学参数。结果对于PTV的参数D98%、V95%、Dmean、CI和HI,双侧晶体的参数Dmin、Dmean和Dmax,双侧泪腺的参数Dmin和Dmean,三维适形和调强技术二者与对穿野技术相比差异均具有统计学意义(P<0.05),但三维适形与调强技术相比差异无统计学意义。对于PTV的参数D2%和双侧泪腺的参数Dmax,则三种技术之间比较差异均无统计学意义。结论三维适形(含电子线照射野)和调强技术与传统的对穿野技术相比都有着同样的剂量学优势,在患者不愿意接受调强技术昂贵的价格或者没有调强设备的时候,可以用三维适形技术代替。展开更多
文摘<strong>Background:</strong> In Graves’s disease, there is a lack of description specific to the gender and age among sub-Saharan African subject. The objective was to evaluate the impact of gender and age on the profile of Graves’ disease in Senegalese subject in order to understand the evolution and improve the therapeutic choices. <strong>Methods:</strong> This is a retrospective study conducted from January 1, 2010 to December 31, 2017 (07 years) at Abass Ndao University Hospital (Senegal), focused on patients with Graves’ disease followed up under antithyroid drugs treatment for at least 18 months. <strong>Results:</strong> There were 244 men, 404 subjects between [0 - 25 years], and 101 subjects more than 50 years old. Factors associated with goitre size were male gender (p < 0.001), young age (p < 0.001). Graves orbitopathy was correlated with male gender (p = 0.015), and young age (p < 0.001). Among 580 patients who had stopped medical treatment after more than 18 months of follow-up, relapse involved in 30.3%. Durable remission was achieved in 38.8% of all included patients and 69.7% of subjects who had a cessation of medical treatment. The factors associated with sustained remission were female gender (p = 0.049), absence of orbitopathy (p = 0.011), small goiter (p < 0.001), advanced age (p = 0.006) and early start of the maintenance treatment (p = 0.006). <strong>Conclusion:</strong> In our Senegalese study, men and young patients are particularized by a trend of voluminous goitre and low rate of remission. These data remain a basis for predicting the outcome of medical treatment and make timely use of radical treatments such as surgery or irratherapy in the presence of risk factors for recurrence.
文摘目的探讨三维适形(含电子线照射野)的照射技术治疗双眶Grave’s眼病的实施方法及其剂量学优势。方法10例确诊为双侧Grave’s眼病的患者,均用三维适形(含电子线照射野)照射技术、传统的对穿野照射技术以及近年来主流的调强照射技术等三种技术完成治疗计划,比较计划靶区(planning target volume,PTV)和危及器官(organ at risk,OAR)的剂量分布图、剂量体积直方图和剂量学参数。结果对于PTV的参数D98%、V95%、Dmean、CI和HI,双侧晶体的参数Dmin、Dmean和Dmax,双侧泪腺的参数Dmin和Dmean,三维适形和调强技术二者与对穿野技术相比差异均具有统计学意义(P<0.05),但三维适形与调强技术相比差异无统计学意义。对于PTV的参数D2%和双侧泪腺的参数Dmax,则三种技术之间比较差异均无统计学意义。结论三维适形(含电子线照射野)和调强技术与传统的对穿野技术相比都有着同样的剂量学优势,在患者不愿意接受调强技术昂贵的价格或者没有调强设备的时候,可以用三维适形技术代替。
